Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Nina A. Hering"'
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
The oleoresin myrrh has been used for centuries as an anti-inflammatory remedy for a variety of diseases and is said to have a protective effect on the intestinal epithelium. An intact epithelial barrier function is the prerequisite for a healthy gut
Externí odkaz:
https://doaj.org/article/c1551ed713084d9eb5896e7ea39a868d
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Scope: Ellagitannins are polyphenols found in numerous fruits, nuts and seeds. The elagitannin punicalagin and its bioactive metabolites ellagic acid and urolithins are discussed to comprise a high potential for therapeutically or preventive medical
Externí odkaz:
https://doaj.org/article/b34af8f70a9f49a9b19751b016e97042
Autor:
Larissa Schawe, Ben Raude, Jan Christoph Carstens, Irene Hinterseher, Raphael Donatus Hein, Safwan Omran, Gilles Berger, Nina A. Hering, Matthias Buerger, Andreas Greiner, Jan Paul Frese
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 471 (2022)
Vascular endothelial growth factor (VEGF) is a potent driver of angiogenesis, which may help to relieve ischemia in peripheral arterial disease (PAD). We aimed to investigate the role of intramuscular VEGF in ischemic and non-ischemic skeletal muscle
Externí odkaz:
https://doaj.org/article/15dd47f6ce684bb19996bec2b85c6f25
Autor:
Ioannis Pozios, Nina A. Hering, Emily Guenzler, Marco Arndt, Sefer Elezkurtaj, Thomas Knösel, Christiane J. Bruns, Georgios A. Margonis, Katharina Beyer, Hendrik Seeliger
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:271-280
Purpose Interleukin 6 (IL-6), Oncostatin M (OSM), and downstream effector STAT3 are pro-tumorigenic agents in pancreatic ductal adenocarcinoma (PDAC). Glycoprotein 130 (gp130) is a compound of the IL-6 and OSM receptor complex that triggers STAT3 sig
Autor:
Ann-Kathrin Berg, Elisabeth M. Hahn, Fiona Speichinger-Hillenberg, Annemaria Silvana Grube, Nina A. Hering, Ani K. Stoyanova, Katharina Beyer
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1773
Despite intensive scientific efforts, the therapy of peritonitis is presently limited to symptomatic measures, including infectious source control and broad-spectrum antibiotics. Promising therapeutic approaches to reduce morbidity and mortality are
Autor:
LUCAS D. LEE, NINA A. HERING, MIRIAM ZIBELL, LEONARD A. LOBBES, CARSTEN KAMPHUES, JOHANNES C. LAUSCHER, GEORGIOS A. MARGONIS, HENDRIK SEELIGER, KATHARINA BEYER, BENJAMIN WEIXLER, IOANNIS POZIOS
Publikováno v:
In Vivo
Background/Aim: Evidence of metastatic disease precludes oncological resection of pancreatic cancer. Near-infrared (NIR) fluorescent labels, such as indocyanine green (ICG), assist in the intraoperative detection of occult and micrometastatic liver d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c6317218a9492bf38d4ae966ecf1491
https://europepmc.org/articles/PMC10026647/
https://europepmc.org/articles/PMC10026647/
Autor:
Marco Arndt, Mario H. Mueller, Elisabeth M. Hahn, Lisa Hartmann, Martin E. Kreis, Nina A. Hering
Publikováno v:
Surgery. 170:1442-1447
Background Postoperative ileus entails pathophysiological changes in mucosal permeability and an intestinal inflammatory immune response. We hypothesized that preoperative selective decontamination of the digestive tract combined with preoperative me
Autor:
Leonard A. Lobbes, Marcel A. Schütze, Raoul Droeser, Marco Arndt, Ioannis Pozios, Johannes C. Lauscher, Nina A. Hering, Benjamin Weixler
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 9; Pages: 8198
Muscarinic acetylcholine receptor M3 (M3R) has repeatedly been shown to be prominently expressed in human colorectal cancer (CRC), playing roles in proliferation and cell invasion. Its therapeutic targetability has been suggested in vitro and in anim
Autor:
Ioannis Pozios, Nina A. Hering, Emily Guenzler, Marco Arndt, Sefer Elezkurtaj, Thomas Knösel, Christiane J. Bruns, Georgios A. Margonis, Carsten Kamphues, Martin E. Kreis, Katharina Beyer, Hendrik Seeliger
Background: Interleukin-6 (IL-6), Oncostatin-M (OSM) and the major downstream effector STAT3 are pro-tumorigenic agents in many cancers, including pancreatic ductal adenocarcinoma (PDAC). Glycoprotein 130 (gp130) is a compound of the IL-6 and OSM rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::247f22b534271cabd2c9e3fa75431200
https://doi.org/10.21203/rs.3.rs-1602630/v1
https://doi.org/10.21203/rs.3.rs-1602630/v1
Autor:
Nina N. Seel, Verena Liu, Mario H. Müller, Ioannis Pozios, Martin E. Kreis, Christiane J. Bruns, Lisa Hartmann, Nina A. Hering, Hendrik Seeliger, Peter Camaj, Lucas D. Lee
Publikováno v:
Cellular Oncology (Dordrecht)
Purpose Currently, the exact role of estrogen receptor (ER) signaling in pancreatic cancer is unknown. Recently, we showed that expression of phosphorylated ERβ correlates with a poor prognosis in patients with pancreatic ductal adenocarcinoma (PDAC